Clinical trial
Intravenous Azithromycin Plus Intravenous Ceftriaxone Followed by Oral…
NCT00035347 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00035347 |
|---|---|
| Title | Intravenous Azithromycin Plus Intravenous Ceftriaxone Followed by Oral Azithromycin With Intravenous Levofloxacin Followed by Oral Levofloxacin for the Treatment of Moderate to Severely Ill Hospitalized Patients With Community Acquired Pneumonia |
| Official title | A Randomized, Multicenter, Open Label Trial Comparing Intravenous Zithromax® (Azithromycin) Plus Intravenous Rocephin® (Ceftriaxone) Followed By Oral Zithromax® (Azithromycin) With Intravenous Levaquin® (Levofloxacin) Followed By Oral Levaquin® (Levofloxacin) For The Treatment Of Moderate To… |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Community-Acquired Pneumonia (CAP) |
| Intervention type | Drug |
| Interventions | IV azithromycin, ceftriaxone, oral azithromycin, IV levofloxacin, oral levofloxacin |
| Enrollment | 219 |
| Start date | Jan 1, 2001 |
| Completion | Jun 1, 2002 |
| First posted | May 6, 2002 |
| Last update posted | Mar 10, 2017 |
| Countries | Canada, Germany, Greece, Spain, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: